Trial intelligence / Profile preview

FLUAD 2007-2008 Formulation in Adults with Chronic Diseases

NCT00522067Phase 2Completed

Sponsor
Novartis
Start
Jun 2007
Primary completion
Jul 2007
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of influenza vaccine (surface antigen, inactivated, adjuvanted) in influenza, sponsored by Novartis. Started Jun 2007; status: completed.

02

Drugs

influenza vaccine (surface antigen, inactivated, adjuvanted)
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00522067.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00522067.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call